Evolution of Income for innovation activity (*)
(*) Evolution of Income for innovation activity. The activities are described in the section: “Revenue collected by type of innovation activities”
Spin-off’s approved in 2020 (*)
| 5 SPIN-OFFS APPROVED IN 2020 | BSURE |
|---|---|
| ENDOLIPID THERAPEUTICS | |
| MIMARK | |
| TENSORMEDICAL | |
| ABCDX |
(*) In 2020, VHIR’s Board of Trustees (Patronato) approved the constitution of five companies participated by VHIR.
Patents 2020
| Patent applications (*) | 2 |
|---|---|
| Utility Model (**) | 1 |
| International Patent Aplication (PCT) (***) | 13 |
| Patents entering national phases (****) | 2 |
| Patents licensed to companies (*****) | 2 |
(*) Patent families applied in 2020
(Patent families are the set of patent applications that derive from a first priority patent application)
(**) Utility Model Families in 2020
(Families are the set of applications that derive from a first Utility Model)
(***) Patent application processed under the Patent Cooperation Treaty (PCT) that allows the application of protection for an invention simultaneously in a large number of countries by filing an “international” patent application.
(****) National patent applications arising from an international PCT application.
(*****) “Families” of Patents for which an exploitation agreement has been signed with a company (in this case called a licensee)
In total, Patents of VHIR
| Patents applied (*) | 111 |
|---|---|
| of which licensed patents | 31 |
(*) All patent families applied for from 2010 to 2020 inclusive
Revenue colected by type of inovation activities
| Licenses (license options, upfronts, royalties, etc.) (*) | 55 575 € |
|---|---|
| Spin-Off’s (licenses, services) (**) | 310 883 € |
| Collaborative Projects (***) | 666 849 € |
| Other Innovation Income (****) | 512 280 € |
(*) Revenue from assets that have been licensed to other companies.
(**) Revenue from SpinOffs in which the VHIR participates
(***) Revenue from companies or other institutions, which goes to research groups and the institution
(****) Revenue from activities such as advice, innovation activities or income intended to finance the staff of the unit.
Other resources captured and confirmed during 2020
| Confirmed income for 2021 for collaborative projects with companies (*) | 1 357 255 € |
|---|---|
| Funding raised by staff and Innovation activities (**) | 493 350 € |
(*) Revenue collection are confirmed for 2021
(**) VHIR is the statewide institute that has raised the most ISCIII funding in staffing and activities of the innovation unit.
